Anteris Technologies Ltd (AVR:ASX)

$3.96

right-arrow Created with Sketch. -0.08 (-1.98%)
Last trade 15.49pm 19/10/2020 20mins delayed

Latest Announcements

16/10/2020 Price SensitivePSAVRAnteris Technologies Ltd
15/10/2020AVRAnteris Technologies Ltd
09/10/2020AVRAnteris Technologies Ltd
24/09/2020AVRAnteris Technologies Ltd
21/09/2020AVRAnteris Technologies Ltd
08/09/2020 Price SensitivePSAVRAnteris Technologies Ltd
31/08/2020AVRAnteris Technologies Ltd
28/08/2020AVRAnteris Technologies Ltd
23,096
MCap

Company Overview

Anteris Technologies Ltd, formerly Admedus Ltd, is an Australia-based structural heart company. The Company provides solutions for heart valves. Its products include ADAPT and DurAVR. ADAPT its anti-calcification treatment platform technology on which its structural heart products are developed. DurAVR, built with ADAPT technology, is a durable three dimension (3D) single-piece aortic valve for the treatment of aortic stenosis. Its DurAVR Development Portfolio includes DurAVR Leaflet Repair (RP), DurAVR Transcatheter Heart Valve (THV) and DurAVR Surgical Heart Valve (SHV).

AVR in the news

Biologic heart valve maker Anteris Technologies (AVR) is continuing to make progress…
Structural heart company Anteris Technologies (AVR) has received a United States patent…

Search Previous Announcements